Direkt zum Inhalt
Merck

Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2013-06-14)
Scott J Moeller, Muhammad A Parvaz, Elena Shumay, Nicasia Beebe-Wang, Anna B Konova, Nelly Alia-Klein, Nora D Volkow, Rita Z Goldstein
ZUSAMMENFASSUNG

Functional polymorphisms in the dopamine transporter gene (DAT1 or SLC6A3) modulate responsiveness to salient stimuli, such that carriers of one 9R-allele of DAT1 (compared with homozygote carriers of the 10R-allele) show heightened reactivity to drug-related reinforcement in addiction. Here, using multimodal neuroimaging and behavioral dependent variables in 73 human cocaine-addicted individuals and 47 healthy controls, we hypothesized and found that cocaine-addicted carriers of a 9R-allele exhibited higher responses to drug cues, but only among individuals who had used cocaine within 72 h of the study as verified by positive cocaine urine screens (a state characterized by intense craving). Importantly, this responsiveness to drug cues was reliably preserved across multimodal imaging and behavioral probes: psychophysiological event-related potentials, self-report, simulated cocaine choice, and fMRI. Because drug cues contribute to relapse, our results identify the DAT1R 9R-allele as a vulnerability allele for relapse especially during early abstinence (e.g., detoxification).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Kokain -Lösung, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Kokain -hydrochlorid
Sigma-Aldrich
Kokain
Supelco
Kokain -hydrochlorid -Lösung, 1.0 mg/mL in methanol, analytical standard, for drug analysis